#KidneyWk on X 1 day ago

RT @Neph_Times: What role do CD38+ immune cells play in AMR and glomerular disease? Georg Böhmig, MD, shares insights from #KidneyWk and wh…

View Post

#KidneyWk on X 1 day ago

RT @edgarvlermamd: Check out the Wolters Kluwer booth and pre-order your copy of “Handbook of Glomerulonephritis” by @ph_nachman @rheault_m…

View Post

#KidneyWk on X 1 day ago

RT @edgarvlermamd: BECK: Suggested treatment algorithm for Membranous Nephropathy from @goKDIGO #KidneyWk #Nephpearls https://t.co/EjdHtYqc…

View Post

#KidneyWk on X 1 day ago

RT @edgarvlermamd: Treatment of Hyponatremia from @NephroMD #Nephpearls #KidneyWk 📌 Use of Hypertonic Saline (HTS) 📌 Management of severe…

View Post

#KidneyWk on X 1 day ago

What role do CD38+ immune cells play in AMR and glomerular disease? Georg Böhmig, MD, shares insights from #KidneyWk and what’s next for CD38-targe...

View Post

#KidneyWk on X 2 days ago

RT @biogen: #News: We announced positive Phase 2 results for our investigational treatment for people living with IgA nephropathy at #Kidne…

View Post

#KidneyWk on X 2 days ago

RT @biogen: #News: We’re presenting new data on an investigational treatment for immunoglobulin A nephropathy (IgAN) at @ASNKidney #KidneyW…

View Post

#KidneyWk on X 2 days ago

RT @biogen: Join us at @ASNKidney #KidneyWk to learn about our ongoing research in kidney disease and our late-stage clinical trials. Find…

View Post

#KidneyWk on X 2 days ago

RT @VertexPharma: We are excited to share new data from multiple investigational kidney disease programs at the 2024 @ASNKidney Week Congre…

View Post

#KidneyWk on X 2 days ago

RT @rheault_m: Late breakers that included children: ✅Setanaxib in Alport (12+) Late breakers that did NOT include children: 🚫Atacicept i…

View Post